Showing results (351-360 of 377) with videos related to
Sort By:
Pageof 38
International Journal of Toxicology|May 15, 2020
An Industry Survey With Focus on Cardiovascular Safety Pharmacology Study Design and Data InterpretationSimon Authier, Matthew M Abernathy, Krystle Correll, et al.ACS Infectious Diseases|March 10, 2021
Violacein-Induced Chaperone System Collapse Underlies Multistage Antiplasmodial ActivityTatyana Almeida Tavella, Noeli Soares Melo da Silva, Natalie Spillman, et al.European Heart Journal. Digital Health|January 30, 2023
Daily angina documentation versus subsequent recall: development of a symptom smartphone appAlexandra N Nowbar, James P Howard, Matthew J Shun-Shin, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 14, 2022
A double-blind randomised placebo-controlled trial of percutaneous coronary intervention for the relief of stable angina without antianginal medications: design and rationale of the ORBITA-2 trialAlexandra N Nowbar, Christopher Rajkumar, Michael Foley, et al.ACS Infectious Diseases|February 2, 2021
Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford Selectivity over the Human Enzyme through Tight Binding InteractionsJohn Ginn, Xiuju Jiang, Shan Sun, et al.Journal of the Society for Cardiovascular Angiography & Interventions|August 22, 2022
Aortic Valve Calcium Score Is Associated With Acute Stroke in Transcatheter Aortic Valve Replacement PatientsMichael Foley, Kerry Hall, James P Howard, et al.Journal of the American Heart Association|January 26, 2021
Achieving Optimal Medical Therapy: Insights From the ORBITA TrialMichael Foley, Christopher A Rajkumar, Matthew Shun-Shin, et al.Nature Communications|June 25, 2021
Oral administration of bovine milk-derived extracellular vesicles induces senescence in the primary tumor but accelerates cancer metastasisMonisha Samuel, Pamali Fonseka, Rahul Sanwlani, et al.Science (New York, N.Y.)|June 2, 2022
Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategyStanley C Xie, Riley D Metcalfe, Elyse Dunn, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Diversity-oriented synthesis yields a new drug lead for treatment of chagas diseaseSivaraman Dandapani, Andrew R Germain, Ivan Jewett, et al.Pageof 38